* Surface Oncology Inc SURF.OQ reported a quarterly adjusted
loss of 44 cents per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 35 cents per share.
* Revenue was $515.00 thousand; analysts expected $2.47
million.
* Surface Oncology Inc's reported EPS for the quarter was a loss
of 44 cents.
* The mean earnings estimate of analysts had fallen by
about 7.7% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Surface Oncology Inc shares had fallen by 24.8% this
quarter and lost 39.3% so far this year.
* The company reported a quarterly loss of $18.98 million.
* Wall Street's median 12-month price target for Surface
Oncology Inc is $15.00
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated August 6 at 06:38 p.m. All
figures in US dollars unless otherwise stated